Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - indapamide hemihydrate - oral tablet - 2.5mg

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - carbimazole - oral tablet - 20mg

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - codeine phosphate - oral tablet - 15mg

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - ciprofibrate - oral tablet - 100mg

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - digoxin, quantity: 250 microgram - tablet, uncoated - excipient ingredients: magnesium stearate; rice starch; lactose monohydrate; oxidised maize starch; hydrolysed maize starch - congestive heart failure - sigmaxin is useful regardless of whether the failure is predominantly of the left or right ventricle, or involves both sides of the heart. it is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. sigmaxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency. atrial fibrillation - because sigmaxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. it will frequently convert atrial flutter into fibrillation and, upon withdrawal of the drug, normal sinus rhythm may be restored. paroxysmal atrial tachycardia - sigmaxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - digoxin, quantity: 0.0625 microgram - tablet, uncoated - excipient ingredients: lactose monohydrate; rice starch; magnesium stearate; hydrolysed maize starch; povidone; indigo carmine; oxidised maize starch - congestive heart failure - sigmaxin is useful regardless of whether the failure is predominantly of the left or right ventricle, or involves both sides of the heart. it is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. sigmaxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency. atrial fibrillation - because sigmaxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. it will frequently convert atrial flutter into fibrillation and, upon withdrawal of the drug, normal sinus rhythm may be restored. paroxysmal atrial tachycardia - sigmaxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - cyproterone acetate - oral tablet - 50mg

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - mupirocin - cutaneous ointment - 20mg/1gram

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - clotrimazole - cutaneous cream - 10mg/1gram

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - ranitidine hydrochloride - oral tablet - 300mg